China Meheco Group Past Earnings Performance
Past criteria checks 3/6
China Meheco Group's earnings have been declining at an average annual rate of -13.8%, while the Healthcare industry saw earnings growing at 4.2% annually. Revenues have been growing at an average rate of 2.4% per year. China Meheco Group's return on equity is 8%, and it has net margins of 2.6%.
Key information
-13.8%
Earnings growth rate
-13.8%
EPS growth rate
| Healthcare Industry Growth | 7.0% |
| Revenue growth rate | 2.4% |
| Return on equity | 8.0% |
| Net Margin | 2.6% |
| Last Earnings Update | 31 Mar 2024 |
Recent past performance updates
Revenue & Expenses BreakdownBeta
How China Meheco Group makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 31 Mar 24 | 35,069 | 925 | 2,498 | 121 |
| 31 Dec 23 | 38,824 | 1,048 | 2,706 | 116 |
| 30 Sep 23 | 40,472 | 563 | 3,008 | 102 |
| 30 Jun 23 | 41,566 | 663 | 3,142 | 99 |
| 31 Mar 23 | 41,603 | 758 | 3,088 | 90 |
| 31 Dec 22 | 37,593 | 736 | 3,028 | 77 |
| 30 Sep 22 | 36,424 | 578 | 2,909 | 70 |
| 30 Jun 22 | 35,621 | 602 | 2,898 | 65 |
| 31 Mar 22 | 36,182 | 680 | 3,051 | 62 |
| 31 Dec 21 | 36,234 | 647 | 3,162 | 57 |
| 30 Sep 21 | 35,773 | 908 | 3,162 | 78 |
| 30 Jun 21 | 38,768 | 1,194 | 3,402 | 78 |
| 31 Mar 21 | 40,399 | 1,260 | 3,561 | 79 |
| 31 Dec 20 | 39,312 | 1,311 | 3,520 | 84 |
| 30 Sep 20 | 39,527 | 1,251 | 3,767 | 88 |
| 30 Jun 20 | 37,234 | 1,070 | 3,877 | 99 |
| 31 Mar 20 | 34,525 | 836 | 4,078 | 111 |
| 31 Dec 19 | 35,285 | 981 | 4,281 | 108 |
| 30 Sep 19 | 34,834 | 1,273 | 4,537 | 105 |
| 30 Jun 19 | 33,337 | 1,393 | 4,472 | 97 |
| 31 Mar 19 | 32,593 | 1,516 | 4,375 | 81 |
| 31 Dec 18 | 31,006 | 1,545 | 4,307 | 86 |
| 30 Sep 18 | 30,943 | 1,546 | 3,815 | 131 |
| 30 Jun 18 | 30,416 | 1,489 | 3,316 | 171 |
| 31 Mar 18 | 30,350 | 1,421 | 2,731 | 160 |
| 31 Dec 17 | 30,357 | 1,313 | 2,194 | 144 |
| 30 Sep 17 | 28,845 | 1,198 | 1,820 | 54 |
| 30 Jun 17 | 28,283 | 1,095 | 1,660 | 0 |
| 31 Mar 17 | 27,250 | 1,024 | 1,554 | 0 |
| 31 Dec 16 | 25,946 | 950 | 1,524 | 0 |
| 30 Sep 16 | 24,812 | 857 | 1,532 | 0 |
| 30 Jun 16 | 23,194 | 760 | 1,462 | 0 |
| 31 Mar 16 | 21,563 | 692 | 1,463 | 0 |
| 31 Dec 15 | 20,570 | 614 | 1,426 | 0 |
| 30 Sep 15 | 19,536 | 646 | 1,290 | 0 |
| 30 Jun 15 | 18,627 | 640 | 1,288 | 0 |
| 31 Mar 15 | 18,259 | 595 | 1,176 | 0 |
| 31 Dec 14 | 17,857 | 550 | 1,123 | 0 |
| 30 Sep 14 | 16,746 | 580 | 989 | 0 |
| 30 Jun 14 | 16,235 | 493 | 998 | 0 |
| 31 Mar 14 | 15,241 | 488 | 967 | 0 |
| 31 Dec 13 | 14,830 | 485 | 953 | 0 |
| 30 Sep 13 | 14,927 | 453 | 1,064 | 0 |
| 30 Jun 13 | 14,622 | 475 | 986 | 0 |
Quality Earnings: 600056 has a large one-off gain of CN¥405.0M impacting its last 12 months of financial results to 31st March, 2024.
Growing Profit Margin: 600056's current net profit margins (2.6%) are higher than last year (1.8%).
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: 600056's earnings have declined by 13.8% per year over the past 5 years.
Accelerating Growth: 600056's earnings growth over the past year (21.9%) exceeds its 5-year average (-13.8% per year).
Earnings vs Industry: 600056 earnings growth over the past year (21.9%) exceeded the Healthcare industry -1%.
Return on Equity
High ROE: 600056's Return on Equity (8%) is considered low.